🧬 Biotech
Catalyst Calendar
Updated daily · catalystalert.io + dansfera.com
Admin
1
Upcoming
1
This Month
0
Trial Readouts
0
PDUFA Dates
1
AdCom Votes
Type:
All
🔬 Trial
💊 PDUFA
🏛️ AdCom
📊 Earnings
Mkt Size:
All
≥$1B
≥$5B
≥$10B
≥$50B
Date
Ticker
Company
Drug
Type
Phase
PoA
Mkt Size
Notes
2026-04-30
in 2 days
AZN
AstraZeneca HR+/HER2- advanced breast cancer — first-line with emergent ESR1 mutation
camizestrant (NDA 220359
AdCom
—
85%
$12B
APR 30 2026 2 days 🏛️ AdCom (camizestrant (NDA 220359)) $AZN AstraZeneca HR+/HER2- advance